Not really. You just have a short taking it down and trying to cover before audit is released. That has nothing to do with the company. Revenues look great and there’s been 0 shares diluted in the 5 years I’ve followed it. Tons of partners throughout the world and the huge uzbekistan pharma park is about to open. Huge opportunity here.
Market Data 
Markets 
AI
